Heres our chart of the results: People with T2D treated with GLP-1RA consistently exhibited a lower risk of suicide attempts compared to those treated with DPP-4i
The focus of preclinical studies has shifted from investigating glucose metabolism alone to exploring more complex mechanisms, such as the metabolic interplay between Schwann cells and axons and the role of insulin resistance in nerve function
I think because these side effects are notable and even perhaps more than is generally recognized as you're bringing up, the concern here is without a exit ramp, we got a lot of potential lurking trouble there
Companies that strengthen quality systems, review promotional activities, verify supply chain integrity, and maintain robust regulatory oversight will be best positioned to: Reduce enforcement risks Maintain operational continuity Protect patient safety Improve inspection readiness Support long-term business success As FDA scrutiny continues increasing across compounded therapeutics and digital healthcare models, strategic compliance planning will remain essential
Washington is spending $250,000 to study a prescription drug benefit that includes FDA-approved weight-loss medications